Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain

Journal of Clinical Microbiology

Volumn 43, Issue 3, 2005, Pages 1220-1227

  Samper, S ^a   Iglesias, M J ^b   Rabanaque, M J ^b   Gomez L I ^b   Lafoz, M C ^b   Jimenez M S ^c   Ortega, A ^d   Lezcano, M A ^a   Van Soolingen, D ^e   Martin C ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KATG PROTEIN; RNA POLYMERASE BETA SUBUNIT;

ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA HYBRIDIZATION; GENE INSERTION SEQUENCE; GENE TRANSFER; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; IMMIGRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; REINFECTION; RESTRICTION FRAGMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPAIN; SPOLIGOTYPE ANALYSIS; TAXONOMY; TUBERCULOSIS;

ADULT; BACTERIAL PROTEINS; CATALASE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 20144374957     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.3.1220-1227.2005     Document Type: Article

References (45)

1. Angarano, G., S. Carbonara, D. Costa, A. Gori, et al. 1998. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. Int. J. Tuberc. Lung. Dis. 2:303-311.
2. Bifani, P. J., B. Mathema, Z. Liu, S. L. Moghazeh, B. Shopsin, B. Tempalski, J. Driscol, R. Frothingham, J. M. Musser, P. Alcabes, and B. N. Kreiswirth. 1999. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 282:2321-2327.
3. Blázquez, J., L. E. Espinosa de Los Monteros, S. Samper, C. Martín, A. Guerrero, J. Cobo, J. Van Embden, F. Baquero, and E. Gómez-Mampaso. 1997. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J. Clin. Microbiol. 35:1390-1393.
4. Caminero, J. A., M. J. Pena, M. I. Campos-Herrero, J. C. Rodriguez, I. García, P. Cabrera, C. Lafoz, S. Samper, H. Takiff, O. Afonso, J. M. Pavon, M. J. Torres, D. van Soolingen, D. A. Enarson, and C. Martín. 2001. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am. J. Respir. Crit. Care Med. 164:1165-1170.
5. Dahle, U. R., P. Sandven, E. Heldal, and D. A. Caugant. 2001. Molecular epidemiology of Mycobacterium tuberculosis in Norway. J. Clin. Microbiol. 39:1802-1807.
6. de Boer, A. S., M. W. Borgdorff, P. E. de Haas, N. J. Nagelkerke, J. D. van Embden, and D. van Soolingen. 1999. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J. Infect. Dis. 180:1238-1244.
7. DiPerri, G., M. Cruciani, M. C. Danzi, R. Luzzati, G. De Checchi, M. Malena, S. Pizzighella, R. Mazzi, M. Solbiati, E. Concia, and D. Bassetti. 1989. Nosocomial epidemic of active tuberculosis in HIV infected patients. Lancet ii:1502-1504.
8. Filliol, I., J. R. Driscoll, D. Van Soolingen, B. N. Kreiswirth, K. Kremer, G. Valetudie, D. D. Anh, R. Barlow, D. Banerjee, P. J. Bifani, K. Brudey, A. Cataldi, R. C. Cooksey, D. V. Cousins, J. W. Dale, O. A. Dellagostin, F. Drobniewski, G. Engelmann, S. Ferdinand, D. Gascoyne-Binzi, M. Gordon, M. C. Gutierrez, W. H. Haas, H. Heersma, G. Kallenius, E. Kassa-Kelembho, T. Koivula, H. M. Ly, A. Makristathis, C. Mammina, G. Martin, P. Mostrom, I. Mokrousov, V. Narbonne, O. Narvskaya, A. Nastasi, S. N. Niobe-Eyangoh, J. W. Pape, V. Rasolofo-Razanamparany, M. Ridell, M. L. Rossetti, F. Stauffer, P. N. Suffys, H. Takiff, J. Texier-Maugein, V. Vincent, J. H. De Waard, C. Sola, and N. Rastogi. 2002. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347-1349.
9. Geng, E., B. Kreiswirth, C. Driver, J. Li, J. Burzynski, P. DellaLatta, A. LaPaz, and N. W. Schluger. 2002. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N. Engl. J. Med. 346:1453-1458.
10. Glynn, J. R., J. Whiteley, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849.
11. Guerrero, A., J. Cobo, J. Fortún, E. Navas, C. Quereda, A. Asensio, J. Canon, J. Blázquez, and E. Gómez-Mampaso. 1997. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 350:1738-1742.
12. Herrera, L., S. Jiménez, A. Valverde, M. A. García-Aranda, and J. A. Sáez-Nieto. 2003. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int. J. Antimicrob. Agents 21:403-408.
13. Iglesias, M. J. 1998. Ph.D. thesis. University of Zaragoza, Zaragoza, Spain.
14. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
15. Kremer, K., D. van Soolingen, R. Frothingham, W. H. Haas, P. W. Hermans, C. Martin, P. Palittapongarnpim, B. B. Plikaytis, L. W. Riley, M. A. Yakrus, J. M. Musser, and J. D. van Embden. 1999. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J. Clin. Microbiol. 37:2607-2618.
16. Li, Z., C. Kelley, F. Collins, D. Rouse, and S. Morris. 1998. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis. 177:1030-1035.
17. Mokrousov, I., O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova, and B. Vyshnevskiy. 2002. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46:1417-1424.
18. Morcillo, N., M. Zumarraga, A. Alito, A. Dolmann, L. Schouls, A. Cataldi, K. Kremer, and D. van Soolingen. 2002. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J. Tuberc. Lung. Dis. 6:959-965.
19. Narvskaya, O., I. Mokrousov, E. Limeschenko, T. Otten, L. Steklova, O. Graschenkova, and B. Vyshnevskiy. 2000. Molecular characterization of Mycobacterium tuberculosis strains from the northwest region of Russia. EpiNorth 1:22-24.
20. Niemann, S., S. Rusch-Gerdes, and E. Richter. 1997. IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J. Clin. Microbiol. 35:3015-3020.
21. Nitta, A. T., L. S. Knowles, J. Kim, E. L. Lehnkering, L. A. Borenstein, P. T. Davidson, S. M. Harvey, and M. L. De Koning. 2002. Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County, California. Am. J. Respir. Crit. Care Med. 165:812-817.
22. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for anti-tuberculosis drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
23. Palenque, E., V. Villena, M. J. Rebollo, M. S. Jimenez, and S. Samper. 1998. Transmission of multidrug-resistant Mycobacterium bovis to an immunocompetent patient. Clin. Infect. Dis. 26:995-996.
24. Portugal, I., M. J. Covas, L. Brum, M. Viveiros, P. Ferrinho, J. Moniz-Pereira, and H. David. 1999. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int. J. Tuberc. Lung Dis. 3:207-213.
25. Pym, A. S., B. Saint-Joanis, and S. T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70:4955-4960.
26. Raviglione, M. C., A. D. Harries, R. Msiska, D. Wilkinson, and P. Nunn. 1997. Tuberculosis and HIV: current status in Africa. AIDS 11:115-123.
27. Ritacco, V., M. Di Lonardo, A. Reniero, M. Ambroggi, L. Barrera, A. Dambrosi, B. Lopez, N. Isola, and I. N. de Kantor. 1997. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J. Infect. Dis. 176:637-642.
28. Rivero, A., M. Marquez, J. Santos, A. Pinedo, M. A. Sanchez, A. Esteve, S. Samper, and C. Martin. 2001. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin. Infect. Dis. 32:159-161.
29. Rodríguez, E. 2001. Situación actual de la tuberculosis en España; incidencia y mortalidad desde 1995. Características de los casos de tuberculosis y meningitis tuberculosa declarados en 2000. Boll. Epidemiol. Sem. 9:293-304.
30. Samper, S., M. J. Iglesias, M. J. Rabanaque, M. A. Lezcano, M. A. Vitoria, M. C. Rubio, R. Gomez-Lus, L. I. Gomez, I. Otal, and C. Martin. 1998. The molecular epidemiology of tuberculosis in Zaragoza, Spain: a retrospective epidemiological study in 1993. Int. J. Tuberc. Lung Dis. 2:281-287.
31. Samper, S., C. Martin, A. Pinedo, A. Rivero, J. Blazquez, F. Baquero, D. van Soolingen, and J. van Embden. 1997. Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis, AIDS 11:1237-1242.
32. Samper, S., M. J. Iglesias, and O. Tello, on behalf of the Spanish Working Group on MDR-TB. 2000. The Spanish multidrug resistant tuberculosis network. Euro Surveill. 5:43-45.
33. Soto, C. Y., M. C. Menéndez, E. Pérez, S. Samper, A. B. Gómez, M. J. García, and C. Martín. 2004. IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks. J. Clin. Microbiol. 42:212-219.
34. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
35. Traore, H., K. Fissette, I. Bastian, M. Devleeschouwer, and F. Portaels. 2000. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 4:481-484.
36. Uhl, J. R., G. S. Ssandhu, B. C. Kline, and F. R. Cockerill III. 1996. PCR-RFLP detection of point mutations in the catalase-peroxidase gene (katG) of M. tuberculosis associated with isoniazid resistance, p. 144-149. In D. H. Persing (ed.), PCR protocols for emerging infectious diseases. ASM Press, Washington, D.C.
37. van Deutekom, H., S. P. Hoijng, P. E. de Haas, M. W. Langendam, A. Horsman, D. van Soolingen, and R. A. Coutinho. 2004. Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier? Am. J. Respir. Crit. Care Med. 169:806-810.
38. van Doorn, H. R., E. J. Kuijper, A. van der Ende, A. G. Welten, D. van Soolingen, P. E. de Haas, and J. Dankert. 2001. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg→Leu mutation at codon 463 of katG are not associated. J. Clin. Microbiol. 39:1591-1594.
39. van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
40. van Soolingen, D., M. W. Borgdorff, P. E. de Haas, M. M. Sebek, J. Veen, M. Dessens, K. Kremer, and J. D. van Embden. 1999. Molecular epidemiology of tuberculosis in The Netherlands: a nation-wide study from 1993 through 1997. J. Infect. Dis. 180:726-736.
41. van Soolingen, D. 2001. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J. Intern. Med. 249:1-26.
42. van Soolingen, D., P. E. de Haas, H. R. van Doorn, E. Kuijper, H. Rinder, and M. W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands. J. Infect. Dis. 182:1788-1790.
43. World Health Organization and International Union Against Tuberculosis and Lung Disease. 2004. Anti-Tuberculosis Drug Resistance in the World. Report no. 3: prevalence and trends. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1999-2002. WHO/TB 2004. World Health Organization, Geneva, Switzerland.
44. World Health Organization. 1998. Report. Multidrug resistant tuberculosis (MDR). Basis for the development of an evidence-based case-management strategy for MDR TB within the WHO'S DOTS strategy. Proceedings of 1998 meetings and protocol recommendations. WHO/CDS/CPC/99.260. [Online.] http://www.who.int/ docstore/gtb/publications/mdrtb/PDF/who.tb .99.260.pdf.
45. Yeh, R. W., A. Ponce de Leon, C. B. Agasino, J. A. Hahn, C. L. Daley, P. C. Hopewell, and P. M. Small. 1998. Stability of Mycobacterium tuberculosis DNA genotypes. J. Infect. Dis. 177:1107-1111.